SCHEMBL6115293

SCHEMBL6115293

O=S(=O)(OCOS(=O)(=O)c1cc(Cl)cc(Cl)c1)c1cc(Cl)cc(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOD1 P00441 1/20 0.38
TSHR P16473 1/20 0.36
FABP4 P15090 3/20 0.36
S100A9 P06702 1/20 0.35
PGR P06401 1/20 0.34
CNR1 P21554 2/20 0.33
ACLY P53396 1/20 0.33
S1PR1 P21453 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
FKBP1A P62942 1/20 0.32
IDO1 P14902 1/20 0.32
FLT1 P17948 1/20 0.32
FLT4 P35916 1/20 0.32
KDR P35968 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15759864 0.83 SOD1 (0.36) SOD1TSHRFABP4S100A9CA1
SCHEMBL6115079 0.80 CA1 (0.39) CA1CA2CA9CYP3A4
SCHEMBL196466 0.79 CYP1A1 (0.39) SOD1TSHRFABP4S100A9PGR
SCHEMBL197290 0.78 STS (0.35) SOD1TSHRFABP4S100A9PGR
SCHEMBL6115151 0.77 ALDH1A1 (0.52) CA1CA2CA9CYP3A4
SCHEMBL6114783 0.76 CA1 (0.41) TSHRCNR1ACLYCA1CA2
SCHEMBL13290848 0.74 TSHR (0.38) SOD1TSHRS100A9PGRACLY
SCHEMBL16467609 0.74 TSHR (0.38) SOD1TSHRFABP4S100A9PGR
SCHEMBL197682 0.74 CA2 (0.46) TSHRCA1CA2CA9
SCHEMBL199101 0.74 CA2 (0.46) TSHRCA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2821395-B1 Novel disulfonic acid ester as an additive for an electrolyte for a lithium secondary battery WAKO PURE CHEM IND LTD (JP) 2017-06-21 EP disclosed
EP-2821395-A2 Novel disulfonic acid ester as an additive for an electrolyte for a lithium secondary battery Wako Pure Chemical Industries, Ltd. (JP) 2015-01-07 EP disclosed
US-8716513-B2 Process for production of bis-quaternary ammonium salt, and novel intermediate WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2014-05-06 US disclosed
EP-2463266-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE Wako Pure Chemical Industries, Ltd. (JP) 2012-06-13 EP disclosed
US-20120130107-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2012-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120130107-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE ASS1, C1S, FHIT SOD1 3481/4885TSHR 689/4885FABP4 3137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.